Patriot Financial Group Insurance Agency, LLC Agios Pharmaceuticals, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$704 Million
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$26.68 - $34.81 $9,338 - $12,183	-350 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$29.58 - $49.78 $5,916 - $9,956	200 Added 133.33%	350 $12,000
Q3 2021 Nov 24, 2021	BUY	$41.92 - $58.18 $6,288 - $8,727	150 New	150 $7,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.6 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account